This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | AlereGmbH |
| Website | http://www.alere.com/de/de.html |
| Twitter username | alere |
| Wikipedia page | https://en.wikipedia.org/wiki/Alere |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 10 | 512,298 | 2,697,030 | -1,956,067 | 0 | 0 | 0 | 418,315 | 512,298 | 522,911 | 945,335 | 1,093,131 | 4,266,608 | 21,641,037 |
| Global health | 10 | 512,298 | 2,697,030 | -1,956,067 | 0 | 0 | 0 | 418,315 | 512,298 | 522,911 | 945,335 | 1,093,131 | 4,266,608 | 21,641,037 |
| Donor | Total | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 26,970,298.00 | 3,866,416.00 | -920,858.00 | 1,965,388.00 | 418,315.00 | 21,641,037.00 |
| Total | 26,970,298.00 | 3,866,416.00 | -920,858.00 | 1,965,388.00 | 418,315.00 | 21,641,037.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 10) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 4,266,608.00 | 2 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop 3 new Malaria Rapid Diagnostic Tests to improve the performance in clinical case management and extend the diagnostic tool for broader Plasmodium species detection; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -400,192.00 | 9 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support Malaria eradication strategies with a new quantitative Malaria Antigen; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 522,911.00 | 5 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To develop malaria Ag P.v or Pan Lactate Dehydrogenase Rapid Diagnostic Test which will be a critical tool in contributing to the Malaria Eradication strategies; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -1,956,067.00 | 10 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to integrate the Alere TB NEAR Assay into the qNAT Analyzer platform. Integrating the Alere TB NEAR Assay into the qNAT Analyzer for True Point of Care TB Diagnostics.. Investment start date: 2/19/2013 to end date: 6/30/2016. Grantee name: Alere Inc.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 512,298.00 | 6 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To develop malaria Ag P.v or Pan Lactate Dehydrogenase Rapid Diagnostic Test which will be a critical tool in contributing to the Malaria Eradication strategies; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,093,131.00 | 3 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop a highly sensitive Plasmodium falciparum HRP2 Malaria rapid diagnostic test (RDT) to identify individuals with low parasite densities who are not diagnosed with current RDTs but contribute significantly to transmission; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -73,078.00 | 8 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop highly sensitive malaria Rapid Diagnostic Tests (RDT) in order to facilitate malaria elimination and eradication goals by detecting and treating parasitemia in, and therefore transmission from, the asymptomatic reservoir; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 945,335.00 | 4 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support Malaria eradication strategies with a new quantitative Malaria Antigen; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 418,315.00 | 7 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop highly sensitive malaria Rapid Diagnostic Tests (RDT) in order to facilitate malaria elimination and eradication goals by detecting and treating parasitemia in, and therefore transmission from, the asymptomatic reservoir; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 21,641,037.00 | 1 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to integrate the Alere TB NEAR Assay into the qNAT Analyzer platform. Integrating the Alere TB NEAR Assay into the qNAT Analyzer for True Point of Care TB Diagnostics.. Investment start date: 2/19/2013 to end date: 6/30/2016. Grantee name: Alere Inc.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |